Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Based upon a presumed direct relationship with LDL lowering and reduction in CV events for persons with vasculopathy, many clinicians enthusiastically embraced the combination of ezetimibe with statins, especially when therapeutic LDL goals were difficult to attain with a statin alone.

Clinical Briefs By Louis Kuritzky, MD